microRNA-20a (miR-20a) in EMT. The expression of miR-20a was analyzed in CRC tissues and cell lines using the reverse transcription-quantitative polymerase chain reaction. Plasmids containing miR-20a short hairpin RNA and miR-20a mimics
XU TAO,CHANGQING JING,YULONG SHI,RUIZHENG MIAO,LIPAN PENG,SHUAI KONG,LI LEPING
2015-01-01
Abstract:The mortality rates associated with colorectal cancer (CRC) are high due to metastasis. Epithelial-to-mesenchymal transition (EMT) is a key step in tumor metastasis. The aim of the present study was to investigate the function of microRNA-20a (miR-20a) in EMT. The expression of miR-20a was analyzed in CRC tissues and cell lines using the reverse transcription-quantitative polymerase chain reaction. Plasmids containing miR-20a short hairpin RNA and miR-20a mimics were transfected into SW620 and LS174T cell lines, respectively. Cell counting kit-8, Transwell® and wound healing assays were performed to assess the effects of miR-20a on cell proliferation, invasion and migration. EMT markers and matrix metalloproteinases (MMPs) were identified using western blotting. The results showed that increased expression of miR-20a in CRC tissues was associated with tumor invasion and lymph node metastasis (P<0.05). Further experiments indicated that miR-20a-knockdown inhibited the proliferation, invasion and migration of CRC cells, upregulated the expression of vimentin and tissue inhibitor of metalloproteinases-2 (TIMP-2) and downregulated the expression of E-cadherin, MMP-2 and MMP-9. The opposite effects were observed in CRC cell lines overexpressing miR-20a. In conclusion, these results have shown that the upregulation of miR-20a suppresses TIMP-2 expression, which subsequently increases the expression of MMP-2 and MMP-9, thereby promoting the EMT of CRC cells. These findings suggest that miR-20a represents a potential therapeutic target for patients with CRC. Introduction According to the GLOBOCAN 2012 statistics, colorectal cancer (CRC) is the third most common cancer in the world. Every year there are ~0.7 million CRC-related mortalities worldwide (1). The usual treatments for CRC are surgery, radiotherapy, chemotherapy and drugs; however, the therapeutic effects of these strategies are insufficient due to the occurrence of invasion and metastasis (2). Tumor metastasis is a complicated process involving multiple steps, one of which is known as the epithelial-to-mesenchymal transition (EMT). As a result of the EMT, epithelial cells gain a mesenchymal phenotype, enabling them to migrate to and invade a distant organ (3). An enhanced understanding of the molecular mechanisms regulating the EMT in CRC is therefore critical for more effective treatments. microRNAs (miRNAs) are small, single-stranded RNA molecules of 20-24 bases in length that belong to the non-coding RNA species. miRNAs regulate gene expression by binding to the 3'-untranslated region (UTR) of their target mRNA, inhibiting translation or degrading the mRNA. To date, >1,400 miRNAs have been identified, and >5,300 human genes have been predicted to be targets of miRNAs (4). miRNAs are involved in numerous biological processes, including embryonic development, cell differentiation and metabolism (5-7). Aberrant miRNA expression in cancer has been found to participate in several pathological processes, such as EMT and other events contributing to tumorigenesis (8,9). miR-20a is a member of the miR-17-92 cluster, which includes miR-17-5p, miR-17-3p, miR-18a, miR-19a, miR-20a, miR-19b-l and miR-92-1, and is located on chromosome 13q31 (10). miR-20a has been reported to be associated with EMT in various types of cancers. In hepatocellular carcinoma (HCC), miR-20a restoration has been shown to inhibit cell proliferation and induce apoptosis by targeting the 3'-UTR of Mcl-1, while decreased expression of miR-20a has been reported to correlate significantly with the aggressive characteristics of HCC cells (11). In addition, the upregulated expression of miR-20a has been found to decrease the migratory ability of oral squamous cell carcinoma (OSCC) cell lines (12), and the ectopic expression of miR-20a has been demonstrated to induce the EMT and enhance the metastasis of gallbladder carcinoma (GBC) cells in vitro and in vivo (13). microRNA-20a enhances the epithelial-to-mesenchymal transition of colorectal cancer cells by modulating matrix metalloproteinases TAO XU, CHANGQING JING, YULONG SHI, RUIZHENG MIAO, LIPAN PENG, SHUAI KONG, YAN MA and LEPING LI Department of Gastrointestinal Surgery, Provincial Hospital Affiliated to Shandong University, Jinan, Shandong 250021, P.R. China Received August 2, 2014; Accepted April 13, 2015 DOI: 10.3892/etm.2015.2538 Correspondence to: Professor Leping Li, Department of Gastrointestinal Surgery, Provincial Hospital Affiliated to Shandong University, 324 Jingwu Road, Jinan, Shandong 250021, P.R. China E-mail: lep_li@163.com